Gregory L Weaver - Net Worth and Insider Trading
Gregory L Weaver Net Worth
The estimated net worth of Gregory L Weaver is at least $10,144 dollars as of 2024-11-29. Gregory L Weaver is the CFO of ATAI Life Sciences NV and owns about 4,666 shares of ATAI Life Sciences NV (ATAI) stock worth over $8,072. Gregory L Weaver is the CFO of Fibrocell Science Inc and owns about 667 shares of Fibrocell Science Inc (FCSC) stock worth over $2,001. Gregory L Weaver is also the Former EVP, CFO, & Director of Atossa Therapeutics Inc and owns about 55 shares of Atossa Therapeutics Inc (ATOS) stock worth over $70. Besides these, Gregory L Weaver also holds Imunon Inc (IMNN) . Details can be seen in Gregory L Weaver's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gregory L Weaver has not made any transactions after 2023-11-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gregory L Weaver
Gregory L Weaver Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gregory L Weaver owns 8 companies in total, including Atossa Therapeutics Inc (ATOS) , Eloxx Pharmaceuticals Inc (ELOX) , and Egalet Corp (EGLTQ) among others .
Click here to see the complete history of Gregory L Weaver’s form 4 insider trades.
Insider Ownership Summary of Gregory L Weaver
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATOS | Atossa Therapeutics Inc | 2023-11-15 | director |
| ELOX | Eloxx Pharmaceuticals Inc | 2017-12-20 | Chief Financial Officer |
| EGLTQ | Egalet Corp | 2019-01-31 | director |
 | | 2014-01-17 | Chief Financial Officer |
| | 2013-03-19 | director |
| | 2010-02-04 | Chief Financial Officer |
| | 2003-07-02 | Chief Financial Officer |
| | 2021-06-22 | Chief Financial Officer |
Gregory L Weaver Latest Holdings Summary
Gregory L Weaver currently owns a total of 4 stocks. Among these stocks, Gregory L Weaver owns 4,666 shares of ATAI Life Sciences NV (ATAI) as of June 22, 2021, with a value of $8,072 and a weighting of 79.58%. Gregory L Weaver owns 667 shares of Fibrocell Science Inc (FCSC) as of November 20, 2013, with a value of $2,001 and a weighting of 19.73%. Gregory L Weaver also owns 55 shares of Atossa Therapeutics Inc (ATOS) as of November 15, 2023, with a value of $70 and a weighting of 0.69%. The other 1 stocks Imunon Inc (IMNN) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Gregory L Weaver
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATAI | ATAI Life Sciences NV | 2021-06-22 | 4,666 | 1.73 | 8,072 |
| FCSC | Fibrocell Science Inc | 2013-11-20 | 667 | 3.00 | 2,001 |
| ATOS | Atossa Therapeutics Inc | 2023-11-15 | 55 | 1.28 | 70 |
| IMNN | Imunon Inc | 2013-03-19 | 0 | 0.86 | 0 |
Holding Weightings of Gregory L Weaver
Gregory L Weaver Form 4 Trading Tracker
According to the SEC Form 4 filings, Gregory L Weaver has made a total of 1 transactions in ATAI Life Sciences NV (ATAI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in ATAI Life Sciences NV is the acquisition of 4,666 shares on June 22, 2021, which cost Gregory L Weaver around $69,990.
According to the SEC Form 4 filings, Gregory L Weaver has made a total of 0 transactions in Fibrocell Science Inc (FCSC) over the past 5 years. The most-recent trade in Fibrocell Science Inc is the acquisition of 667 shares on November 20, 2013, which cost Gregory L Weaver around $35,100.
According to the SEC Form 4 filings, Gregory L Weaver has made a total of 3 transactions in Atossa Therapeutics Inc (ATOS) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Atossa Therapeutics Inc is the sale of 50,000 shares on November 15, 2023, which brought Gregory L Weaver around $32,500.
More details on Gregory L Weaver's insider transactions can be found in the Insider Trading History of Gregory L Weaver table.Insider Trading History of Gregory L Weaver
- 1
Gregory L Weaver Trading Performance
GuruFocus tracks the stock performance after each of Gregory L Weaver's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gregory L Weaver is -2.46%. GuruFocus also compares Gregory L Weaver's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gregory L Weaver within 3 months outperforms 2 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gregory L Weaver's insider trading performs compared to the benchmark.
Performance of Gregory L Weaver
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.55 | | | | | |
| Relative Return to S&P 500(%) | 1.94 | | | | | |
Gregory L Weaver Ownership Network
Gregory L Weaver Owned Company Details
What does Atossa Therapeutics Inc do?
Who are the key executives at Atossa Therapeutics Inc?
Gregory L Weaver is the director of Atossa Therapeutics Inc. Other key executives at Atossa Therapeutics Inc include SVP & Finance and Accounting Heather Rees , CFO & General Counsel Kyle Guse , and director & 10 percent owner & Chief Scientific Officer Shu-chih Chen .
Atossa Therapeutics Inc (ATOS) Insider Trades Summary
Over the past 18 months, Gregory L Weaver made 2 insider transaction in Atossa Therapeutics Inc (ATOS) with a net sale of 0. Other recent insider transactions involving Atossa Therapeutics Inc (ATOS) include a net purchase of 25,000 shares made by Jonathan Finn ,
In summary, during the past 3 months, insiders sold 0 shares of Atossa Therapeutics Inc (ATOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 50,000 shares of Atossa Therapeutics Inc (ATOS) were sold and 75,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.
Atossa Therapeutics Inc (ATOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atossa Therapeutics Inc Insider Transactions
Gregory L Weaver Mailing Address
Above is the net worth, insider trading, and ownership report for Gregory L Weaver. You might contact Gregory L Weaver via mailing address: 185 Berry Street, Suite 6504, San Francisco Ca 94107.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
